NCT06232889View on ClinicalTrials.gov

Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2027

Conditions
Fluorodeoxyglucose F18Phosphoric Monoester HydrolasesPhosphoric Diester Hydrolases
Interventions
DIAGNOSTIC_TEST

Deuterium Glucose Metabolic Imaging with MRI spectroscopy

MRI spectroscopy of the liver, following ingestion of 20 mg deuterium glucose p.o., prior to and after radioembolization treatment for mCRC

Trial Locations (1)

3508 GA

RECRUITING

UMC Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER